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Diabetic macular edema (DME) is one of the main complications of diabetic retin-
opathy [1]. This pathology is owed to impairment of the blood-retinal barrier (BRB) 
[2]. Many factors, such as hypoxia, contribute to barrier dysfunction and progression 
of the disease. Low oxygen tension is one of the main events involved in the forma-
tion of new blood vessels that characterize the typical uncontrolled angiogenesis in 
proliferative stage of diabetic retinopathy. In the last decades, various studies have 
focused their attention on the role of pituitary adenylate cyclase-activating poly-
peptide (PACAP) and vasoactive intestinal peptide (VIP) in the pathophysiology of 
DME. However, the effects of these peptides in maintaining the integrity of the BRB 
exposed to hypoxia remains to be elucidated. In the present work we have studied, 
for the first time, the effect of these peptides on outer BRB integrity following hypox-
ic insult in an experimental model of DME. To this end, we have used the human 
retinal pigment epithelial cells (ARPE-19) to test the effect of both peptides on cel-
lular permeability, transepithelial electrical resistance, tight junctions expression and 
hypoxia-induced apoptosis. Results have demonstrated that both PACAP and VIP are 
able to rescue the integrity of cell monolayer during the hypoxic event, minimizing 
apoptotic damages induced by low tissue oxygen tension through the activation of 
phosphoinositide 3 kinase /Akt and mammalian mitogen activated protein kinase/
Erk kinase signaling pathways. Furthermore, these peptides modulate the expression 
of vascular endothelial growth factor which is one of the downstream transcription 
factor activated during the hypoxic process. In conclusion, we have demonstrated 
that PACAP and VIP are able to counteract the damage induced by hypoxia on BRB 
through the modulation of hypoxia inducible factors expression. 
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